Assertio Holdings Inc (ASRT)
1.07
+0.05
(+4.90%)
USD |
NASDAQ |
May 17, 16:00
1.08
+0.01
(+0.93%)
After-Hours: 20:00
Assertio Holdings Gross Profit (TTM): 109.32M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 109.32M |
December 31, 2023 | 125.05M |
September 30, 2023 | 146.12M |
June 30, 2023 | 147.76M |
March 31, 2023 | 142.14M |
December 31, 2022 | 137.48M |
September 30, 2022 | 121.58M |
June 30, 2022 | 113.80M |
March 31, 2022 | 104.65M |
December 31, 2021 | 95.18M |
September 30, 2021 | 90.15M |
June 30, 2021 | 95.83M |
March 31, 2021 | 89.76M |
December 31, 2020 | 86.40M |
September 30, 2020 | 119.66M |
June 30, 2020 | 144.46M |
March 31, 2020 | 184.16M |
December 31, 2019 | 220.00M |
September 30, 2019 | 205.23M |
June 30, 2019 | 226.85M |
March 31, 2019 | 232.29M |
December 31, 2018 | 293.29M |
September 30, 2018 | 328.10M |
June 30, 2018 | 331.60M |
March 31, 2018 | 351.81M |
Date | Value |
---|---|
December 31, 2017 | 308.13M |
September 30, 2017 | 332.68M |
June 30, 2017 | 344.94M |
March 31, 2017 | 359.92M |
December 31, 2016 | 368.48M |
September 30, 2016 | 357.39M |
June 30, 2016 | 351.05M |
March 31, 2016 | 326.98M |
December 31, 2015 | 274.84M |
September 30, 2015 | 376.03M |
June 30, 2015 | 340.05M |
March 31, 2015 | 331.46M |
December 31, 2014 | 375.22M |
September 30, 2014 | 222.30M |
June 30, 2014 | 210.05M |
March 31, 2014 | 175.27M |
December 31, 2013 | 127.12M |
September 30, 2013 | 112.95M |
June 30, 2013 | 108.76M |
March 31, 2013 | 93.15M |
December 31, 2012 | 84.78M |
September 30, 2012 | 72.02M |
June 30, 2012 | 55.87M |
March 31, 2012 | 62.28M |
December 31, 2011 | 127.43M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
86.40M
Minimum
Dec 2020
226.85M
Maximum
Jun 2019
135.28M
Average
123.32M
Median
Gross Profit (TTM) Benchmarks
Ocular Therapeutix Inc | 54.45M |
Vertex Pharmaceuticals Inc | 8.847B |
Cormedix Inc | -0.8185M |
Verastem Inc | -- |
CytomX Therapeutics Inc | -- |